Delta-Fly Pharma, Inc. (TYO:4598)

Delta-Fly Pharma Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	240	338	1,417	844	1,268	2,088
Cash & Short-Term Investments	240	338	1,417	844	1,268	2,088
Cash Growth	-67.48%	-76.15%	67.89%	-33.44%	-39.27%	7.46%
Other Receivables	39	51	-	-	-	-
Receivables	39	51	-	-	-	-
Prepaid Expenses	-	2	2	3	5	7
Other Current Assets	8	3	13	19	7	20
Total Current Assets	287	394	1,432	866	1,280	2,115
Property, Plant & Equipment	35	36	38	38	39	41
Long-Term Investments	3	2	2	1	3	4
Other Long-Term Assets	1	2	2	1	2	1
Total Assets	326	434	1,474	906	1,324	2,161
Current Income Taxes Payable	117	154	238	113	89	80
Other Current Liabilities	2	2	3	2	2	2
Total Current Liabilities	119	156	241	115	91	82
Other Long-Term Liabilities	1	2	2	1	1	1
Total Liabilities	120	158	243	116	92	83
Common Stock	5,702	5,113	4,731	3,795	3,352	3,291
Additional Paid-In Capital	5,682	5,093	4,711	3,775	3,332	3,271
Retained Earnings	-11,179	-9,931	-8,210	-6,780	-5,451	-4,484
Comprehensive Income & Other	1	1	-1	-	-1	-
Shareholders' Equity	206	276	1,231	790	1,232	2,078
Total Liabilities & Equity	326	434	1,474	906	1,324	2,161
Net Cash (Debt)	240	338	1,417	844	1,268	2,088
Net Cash Growth	-67.48%	-76.15%	67.89%	-33.44%	-39.27%	7.74%
Net Cash Per Share	22.06	38.41	197.05	148.95	234.09	453.49
Filing Date Shares Outstanding	11.96	9.71	8.22	6.29	5.42	4.9
Total Common Shares Outstanding	11.96	9.71	8.22	6.29	5.42	4.9
Working Capital	168	238	1,191	751	1,189	2,033
Book Value Per Share	17.22	28.42	149.72	125.68	227.33	423.78
Tangible Book Value	206	276	1,231	790	1,232	2,078
Tangible Book Value Per Share	17.22	28.42	149.72	125.68	227.33	423.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.